Noboru Imai

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Heart Rate Variability

Artificial Intelligence

Chronic Rhinosinusitis

Ejection Fraction

Top Venues

Life (Basel, Switzerland)

Scientific reports

Expert opinion on drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Mariko Okada, Masahito Katsuki, Tomokazu Shimazu, Takao Takeshima, Takashi Mitsufuji, Yasuo Ito, Katsumi Ohbayashi, Noboru Imai, Junichi Miyahara, Yasuhiko Matsumori, Yoshihiko Nakazato, Kazuki Fujita, Eri Hoshino, Toshimasa Yamamoto
Preliminary External Validation Results of the Artificial Intelligence-Based Headache Diagnostic Model: A Multicenter Prospective Observational Study. Life (Basel, Switzerland) 14 (6) (2024)
Mariko Okada, Masahito Katsuki, Tomokazu Shimazu, Takao Takeshima, Takashi Mitsufuji, Yasuo Ito, Katsumi Ohbayashi, Noboru Imai, Junichi Miyahara, Yasuhiko Matsumori, Yoshihiko Nakazato, Kazuki Fujita, Eri Hoshino, Toshimasa Yamamoto
Preliminary External Validation Results of the Artificial Intelligence-Based Headache Diagnostic Model: A Multicenter Prospective Observational Study. Life (Basel, Switzerland) 14 (6) (2024)
Shigekazu Kitamura, Noboru Imai, Yuka Tanji, Akichika Ozeki, Mika Komori
Lasmiditan in Japanese Patients with Common Migraine Comorbidities or Concomitant Medications: A Post Hoc Safety and Efficacy Analysis from the MONONOFU Study. Journal of pain research 16 (2023)
Koichi Hirata, Takao Takeshima, Noboru Imai, Hisaka Igarashi, Masako Shiosakai, Masanobu Inage, Fumi Sakurai, Xiaoping Ning, Masami Nakai, Nobuyuki Koga
A multicenter, open-label, phase 3 study to evaluate the safety of fremanezumab for migraine, subcutaneously self-administered with an auto-injection device at institutional sites and at home. Expert opinion on drug safety (2022)
Fumihiko Sakai, Norihiro Suzuki, Byung-Kun Kim, Yoshihisa Tatsuoka, Noboru Imai, Xiaoping Ning, Miki Ishida, Kaori Nagano, Katsuhiro Iba, Hiroyuki Kondo, Nobuyuki Koga
Efficacy and safety of fremanezumab for episodic migraine prevention: Multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in Japanese and Korean patients. Headache 61 (7) (2021)
Noboru Imai, Eiji Kitamura
Differences in clinical features of cluster headache between drinkers and nondrinkers in Japan. PloS one 14 (11) (2019)
Daisuke Danno, Miho Iigaya, Noboru Imai, Hisaka Igarashi, Takao Takeshima
The safety and preventive effects of a supraorbital transcutaneous stimulator in Japanese migraine patients. Scientific reports 9 (1) (2019)